iRhythm Technologies, Inc. (IRTC) Financial Ratios
13 years of historical data (2013–2025) · Healthcare · Medical - Devices
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
112.01
↓-32% vs avg
5yr avg: 164.50
30Y Low164.5·High164.5
P/B Ratio
↑
24.66
+14% vs avg
5yr avg: 21.54
30Y Low1.7·High37.2
ROE
↓
-36.6%
↓+25% vs avg
5yr avg: -48.8%
30Y Low-295%·High-18%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
IRTC Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
iRhythm Technologies, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 112.0x P/FCF, 32% below the 5-year average of 164.5x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $3.9B | $5.7B | $2.8B | $3.3B | $2.8B | $3.5B | $6.6B | $1.7B | $1.7B | $1.3B | $159M |
| Enterprise Value | $4.4B | $6.2B | $3.1B | $3.4B | $2.9B | $3.4B | $6.6B | $1.8B | $1.7B | $1.3B | $139M |
| P/E Ratio → | -84.68 | — | — | — | — | — | — | — | — | — | — |
| P/S Ratio | 5.18 | 7.60 | 4.75 | 6.63 | 6.82 | 10.69 | 24.83 | 8.02 | 11.27 | 12.79 | 2.47 |
| P/B Ratio | 24.66 | 37.18 | 30.94 | 15.55 | 11.69 | 12.35 | 19.27 | 12.70 | 30.49 | 15.94 | 1.71 |
| P/FCF | 112.01 | 164.50 | — | — | — | — | — | — | — | — | — |
| P/OCF | 47.82 | 70.23 | 829.78 | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
IRTC EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 8.26 | 5.29 | 6.82 | 6.95 | 10.66 | 24.96 | 8.52 | 11.37 | 13.05 | 2.17 |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | 178.85 | — | — | — | — | — | — | — | — | — |
IRTC Profitability
Margins and return-on-capital ratios measuring operating efficiency
iRhythm Technologies, Inc. earns an operating margin of -4.9%. Operating margins have expanded from -25.4% to -4.9% over the past 3 years, signaling improving operational efficiency. A negative ROE of -36.6% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 70.6% | 70.6% | 68.9% | 67.3% | 68.5% | 66.2% | 73.5% | 75.5% | 73.7% | 71.5% | 67.4% |
| Operating Margin | -4.9% | -4.9% | -19.5% | -25.4% | -27.7% | -31.0% | -16.5% | -25.5% | -31.0% | -27.8% | -24.3% |
| Net Profit Margin | -6.0% | -6.0% | -19.1% | -25.0% | -28.3% | -31.4% | -16.5% | -25.4% | -34.2% | -30.0% | -32.6% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -36.6% | -36.6% | -75.3% | -54.9% | -44.7% | -32.6% | -18.4% | -57.5% | -75.2% | -34.6% | -22.6% |
| ROA | -4.6% | -4.6% | -16.6% | -28.0% | -25.5% | -20.8% | -10.7% | -25.6% | -39.9% | -21.9% | -23.7% |
| ROIC | -5.2% | -5.2% | -24.3% | -31.5% | -30.4% | -23.2% | -10.6% | -26.3% | -39.4% | -23.3% | — |
| ROCE | -4.4% | -4.4% | -20.2% | -36.5% | -31.0% | -24.3% | -12.5% | -31.9% | -45.3% | -23.3% | -20.2% |
IRTC Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $495M ($731M total debt minus $236M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 4.79 | 4.79 | 8.11 | 0.62 | 0.55 | 0.42 | 0.36 | 0.95 | 0.64 | 0.43 | 0.35 |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | 3.24 | 3.49 | 0.45 | 0.22 | -0.04 | 0.10 | 0.80 | 0.27 | 0.32 | -0.21 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | 14.34 | — | — | — | — | — | — | — | — | — |
| Interest Coverage | -2.80 | -2.80 | -7.79 | -32.60 | -27.01 | -85.39 | -27.70 | -32.17 | -15.16 | -7.78 | -5.44 |
IRTC Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
iRhythm Technologies, Inc.'s current ratio of 4.63x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has improved from 2.15x to 4.63x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.63 | 4.63 | 5.82 | 2.15 | 3.24 | 3.48 | 5.75 | 3.32 | 3.52 | 5.72 | 8.98 |
| Quick Ratio | 4.48 | 4.48 | 5.70 | 2.02 | 3.07 | 3.36 | 5.67 | 3.24 | 3.45 | 5.64 | 8.87 |
| Cash Ratio | 3.84 | 3.84 | 4.83 | 1.25 | 2.39 | 2.72 | 5.10 | 2.70 | 2.59 | 4.89 | 8.02 |
| Asset Turnover | — | 0.73 | 0.64 | 1.14 | 0.92 | 0.70 | 0.52 | 0.70 | 1.23 | 0.74 | 0.46 |
| Inventory Turnover | 10.16 | 10.16 | 13.13 | 11.51 | 8.53 | 10.64 | 13.23 | 13.00 | 18.81 | 16.76 | 15.02 |
| Days Sales Outstanding | — | 36.98 | 49.30 | 45.55 | 44.34 | 52.50 | 41.20 | 40.60 | 49.05 | 47.69 | 53.58 |
IRTC Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
iRhythm Technologies, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | 0.9% | 0.6% | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.2% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.2% | 0.0% | 0.0% |
| Shares Outstanding | — | $32M | $31M | $31M | $30M | $29M | $28M | $25M | $24M | $23M | $5M |
Peer Comparison
Compare IRTC with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 IRTCYou | $4B | -84.7 | — | 112.0 | 70.6% | -4.9% | -36.6% | -5.2% | — |
 ITGR | $3B | 29.9 | 13.0 | 28.2 | 23.1% | 11.3% | 6.1% | 5.4% | 4.2 |
 INVA | $2B | 6.8 | 8.0 | 9.8 | 72.3% | 38.5% | 29.1% | 14.2% | 1.3 |
 BDX | $52B | 24.8 | 14.0 | 19.6 | 45.4% | 11.8% | 6.5% | 4.3% | 3.8 |
 HOLX | $17B | 30.5 | 17.4 | 18.4 | 61.0% | 17.4% | 11.1% | 9.4% | 2.6 |
 NVCR | $2B | -13.5 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 MDT | $99B | 21.5 | 14.3 | 19.2 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 |
 ABT | $150B | 11.3 | 15.7 | 23.6 | 50.8% | 16.3% | 30.9% | 9.9% | 1.5 |
 BSX | $83B | 28.9 | 25.1 | 22.8 | 69.0% | 19.8% | 12.4% | 8.8% | 3.3 |
 SJM | $10B | -8.4 | — | 12.6 | 38.8% | -7.7% | -17.9% | -3.4% | — |
 LIVN | $4B | -14.9 | 14.3 | 20.9 | 67.7% | 14.4% | -19.2% | 11.5% | 2.0 |
| Healthcare Median | — | 22.1 | 14.1 | 18.7 | 63.9% | -5.3% | -33.7% | -10.8% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 13 years · Updated daily
See IRTC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs IRTC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare IRTC vs ITGR
Side-by-side business, growth, and profitability comparison vs Integer Holdings Corporation.
Start ComparisonIRTC — Frequently Asked Questions
Quick answers to the most common questions about buying IRTC stock.
What is iRhythm Technologies, Inc.'s P/E ratio?
iRhythm Technologies, Inc.'s current P/E ratio is -84.7x. This places it at the 50th percentile of its historical range.
What is iRhythm Technologies, Inc.'s ROE?
iRhythm Technologies, Inc.'s return on equity (ROE) is -36.6%. The historical average is -84.5%.
Is IRTC stock overvalued?
Based on historical data, iRhythm Technologies, Inc. is trading at a P/E of -84.7x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are iRhythm Technologies, Inc.'s profit margins?
iRhythm Technologies, Inc. has 70.6% gross margin and -4.9% operating margin.